Abstracts (HTML) Autorenliste

Farin, G

Bislang vernachlässigte Parameter bei EPE, EMR und ESD und die Rolle der Endoskopischen Submukosa Resektion (ESR)

Feagan, B

ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT

Feichtenschlager, T

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

Feldbacher, N

Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Fibroscan® probe selection for lean adults
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis

Felder, T

The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects

Feldman, A

The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects

Ferenci, P

Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication

Ferlitsch, M

Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program

Ferrusquía-Acosta, J

SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease

Fickert, P

Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency

Fink, N

Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use

Finn, R

Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)

Flatscher, K

Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center

Forns, X

SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease

Frick, A

Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification

Fuchs, CD

Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling

Fuchssteiner, H

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

Fürschuß, L

A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency